bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$122.6800
|
|
VA NC
|
|
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$235.6447
|
|
AUS PBS
|
generic
|
Avastin (1) |
Roche Products Pty Ltd |
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$425.2700
|
|
VA Big4
|
|
MVASI (1) |
Amgen USA, Inc. |
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$425.9800
|
|
VA Big4
|
|
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$533.8700
|
|
VA FSS
|
|
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$547.6640
|
|
VA Big4
|
|
Avastin (10) |
Genentech USA |
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$562.4200
|
|
VA Big4
|
|
Avastin (1) |
Genentech USA |
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$765.7800
|
|
VA FSS
|
|
Avastin (1) |
Genentech USA |
|
bevacizumab 100 mg / 4 mL (4 mL INJECTION)
|
$796.9400
|
|
VA FSS
|
|
Avastin (10) |
Genentech USA |
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$490.7200
|
|
VA NC
|
|
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$942.5710
|
|
AUS PBS
|
generic
|
Avastin (1) |
Roche Products Pty Ltd |
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$1696.3100
|
|
VA Big4
|
|
MVASI (1) |
Amgen USA, Inc. |
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$1704.0200
|
|
VA Big4
|
|
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$2135.5000
|
|
VA FSS
|
|
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$2176.0260
|
|
VA Big4
|
|
Avastin (10) |
Genentech USA |
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$2200.5400
|
|
VA Big4
|
|
Avastin (1) |
Genentech USA |
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$3063.1200
|
|
VA FSS
|
|
Avastin (1) |
Genentech USA |
|
bevacizumab 400 mg / 16 mL (16 mL INJECTION)
|
$3187.7600
|
|
VA FSS
|
|
Avastin (10) |
Genentech USA |
|